Department of Metabolism and Clinical Nutrition, Kyoto University Hospital, Kyoto, Japan.
Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Clin Transplant. 2019 Jun;33(6):e13566. doi: 10.1111/ctr.13566. Epub 2019 May 12.
Japanese patients with interstitial lung disease (ILD) sometimes die waiting for lung transplantation (LTx) because it takes about 2 years to receive it in Japan. We evaluated nutrition-related factors associated with waiting list mortality. Seventy-six ILD patients were hospitalized in Kyoto University Hospital at registration for LTx from 2013 to 2015. Among them, 40 patients were included and analyzed. Patient background was as follows: female, 30%; age, 50.3 ± 6.9 years; body mass index, 21.1 ± 4.0 kg/m ; 6-minute walk distance (6MWD), 356 ± 172 m; serum albumin, 3.8 ± 0.4 g/dL; serum transthyretin (TTR), 25.3 ± 7.5 mg/dL; and C-reactive protein, 0.5 ± 0.5 mg/dL. Median observational period was 497 (range 97-1015) days, and median survival time was 550 (95% CI 414-686) days. Survival rate was 47.5%, and mortality rate was 38.7/100 person-years. Cox analyses showed that TTR (HR 0.791, 95% CI 0.633-0.988) and 6MWD (HR 0.795, 95% CI 0.674-0.938) were independently correlated with mortality and were influenced by body fat mass and leg skeletal muscle mass, respectively. It is suggested that nutritional markers and exercise capacity are important prognostic markers in waitlisted patients, but further study is needed to determine whether nutritional intervention or exercise can change outcomes.
日本患有间质性肺病 (ILD) 的患者有时会在等待肺移植 (LTx) 时死亡,因为在日本大约需要 2 年的时间才能接受 LTx。我们评估了与等待名单死亡率相关的营养相关因素。2013 年至 2015 年,76 名ILD 患者在京都大学医院登记接受 LTx 住院治疗。其中,40 名患者被纳入并进行了分析。患者背景如下:女性,30%;年龄,50.3±6.9 岁;体重指数,21.1±4.0kg/m²;6 分钟步行距离(6MWD),356±172m;血清白蛋白,3.8±0.4g/dL;血清转甲状腺素蛋白(TTR),25.3±7.5mg/dL;C-反应蛋白,0.5±0.5mg/dL。中位观察期为 497 天(范围 97-1015 天),中位生存时间为 550 天(95%CI 414-686 天)。生存率为 47.5%,死亡率为 38.7/100 人年。Cox 分析显示,TTR(HR 0.791,95%CI 0.633-0.988)和 6MWD(HR 0.795,95%CI 0.674-0.938)与死亡率独立相关,分别受体脂肪量和下肢骨骼肌量的影响。这表明营养标志物和运动能力是等待名单患者的重要预后标志物,但需要进一步研究确定营养干预或运动是否可以改变结局。